Specialist Working Group for Neurology Proposed changes to the Criteria for the clinical use of intravenous immunoglobulin in Australia, Second Edition CRITERIA FOR THE CLINICAL USE OF ITEM INTRAVENOUS IMMUNOGLOBULIN IN PROPOSED CHANGES TO THE CRITERIA RATIONALE FOR PROPOSED CHANGES AUSTRALIA, SECOND EDITION (CRITERIA) Condition IgM paraproteinaemic neuropathy) IgM paraproteinaemic demyelinating neuropathy Addition: added to qualify “demyelinating” Name paraproteinaemic neuropathies and distinguish from axonal types. (A) Specialty Neurology Neurology 6 6 Chapter Specific Conditions of Conflicting evidence of benefit (). Conflicting evidence of benefit (). Evidence
Specialist Working Group for Neurology Proposed changes to the Criteria for the clinical use of intravenous immunoglobulin in Australia, Second Edition ITEM CRITERIA FOR THE CLINICAL USE OF INTRAVENOUS IMMUNOGLOBULIN IN AUSTRALIA, SECOND EDITION (CRITERIA) PROPOSED CHANGES TO THE CRITERIA RATIONALE FOR PROPOSED CHANGES Condition Name IgM paraproteinaemic neuropathy) IgM paraproteinaemic demyelinating neuropathy Addition: “demyelinating” added to qualify paraproteinaemic neuropathies and distinguish from axonal types. (A) Specialty Neurology Neurology Chapter 6 6 Specific Conditions of Evidence Conflicting evidence of benefit (). Conflicting evidence of benefit ().
igm-paraproteinaemic-demyelinating-neuropathy_1.DOCX